Stock 000566 HAINAN HAIYAO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hainan Haiyao Co., Ltd.

Equities

000566

CNE0000004W8

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-14 pm EDT 		5-day change 1st Jan Change
3.6 CNY -1.37% Intraday chart for Hainan Haiyao Co., Ltd. -5.76% -20.35%
Apr. 29 Hainan Haiyao Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 26 Hainan Haiyao Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

HAINAN HAIYAO CO., LTD. is a China-based company principally engaged in the research, development, manufacture and sale of medicines and medical instrument. The Company’s main products consist of six categories, including cephalosporin series, stomach and intestine medicines, anti-tumor medicines, cochlear implant series, bulk drugs and intermediate series. The Company distributes its products in domestic market and to overseas market, with China as its main market.

Number of employees: 2,247

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Preparations
58.8 %
914 51.4 % 856 58.8 % -6.35%
Raw Materials
36.6 %
463 26.0 % 532 36.6 % +15.00%
Inter-segment Elimination
-22.8 %
-436 -24.5 % -332 -22.8 % -23.92%
Others
15.5 %
645 36.2 % 226 15.5 % -64.98%
Traditional Chinese Medicine Warehousing and Trade
11.9 %
194 10.9 % 174 11.9 % -10.31%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
97.6 %
1,677 94.3 % 1,442 97.6 % -13.98%
Foreign
2.4 %
102 5.7 % 36 2.4 % -64.59%

Managers

Managers TitleAgeSince
Jun Hong Wang CEO
 Chief Executive Officer 55 22-04-07
Rong Yi Xu DFI
 Director of Finance/CFO 53 21-06-28
Jian Min Zhang CTO
 Chief Tech/Sci/R&D Officer 46 -
Hai Feng Yin CTO
 Chief Tech/Sci/R&D Officer 52 23-05-30
Yue Xiang Zhao BRD
 Director/Board Member 56 20-03-23
Xi Cheng Liu BRD
 Director/Board Member 62 05-04-15
Xiao Su Wang IRC
 Investor Relations Contact - -
Lei Shi SEC
 Corporate Secretary 38 21-09-26
Hui Zhang PRN
 Corporate Officer/Principal 53 02-12-31

Members of the board

Members of the board TitleAgeSince
Xi Cheng Liu BRD
 Director/Board Member 62 05-04-15
Duo Jia Feng BRD
 Director/Board Member 66 -
Jun Hong Wang CEO
 Chief Executive Officer 55 22-04-07
Xiu Qun Hu BRD
 Director/Board Member 51 23-05-30
Chang Liu BRD
 Director/Board Member 34 19-02-28
Yue Xiang Zhao BRD
 Director/Board Member 56 20-03-23
Qiang Zhang BRD
 Director/Board Member 66 -
Zeng Fu Zhang CHM
 Chairman 59 20-03-23
Ya Dong Zhou BRD
 Director/Board Member 47 -
Shu Xiong Han BRD
 Director/Board Member 39 23-05-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,297,365,126 756,679,688 ( 58.32 %) 0 58.32 %

Shareholders

NameEquities%Valuation
Xi Cheng Liu
25.70 %
299,510,387 25.70 % 152 M ¥
Yunnan International Trust Co., Ltd.
9.200 %
107,216,412 9.200 % 54 M ¥
J.K. Life Insurance Co., Ltd.
3.458 %
40,294,844 3.458 % 20 M ¥
Jing Hu
3.092 %
36,028,600 3.092 % 18 M ¥
Xi De Yang
1.642 %
19,132,305 1.642 % 10 M ¥
Hangzhou Tongwu Investment Management LP
1.123 %
13,082,500 1.123 % 7 M ¥
Su Fen Zhang
0.8907 %
10,380,000 0.8907 % 5 M ¥
Jin Song Guo
0.7415 %
8,641,010 0.7415 % 4 M ¥
JPMorgan Chase Bank, NA (Investment Management)
0.5169 %
6,023,458 0.5169 % 3 M ¥
China Asset Management Co., Ltd.
0.1092 %
1,273,100 0.1092 % 645 207 ¥
NameEquities%Valuation
Xi Cheng Liu
99.13 %
130,825,900 99.13 % 66 M ¥

Company contact information

Hainan Haiyao Co., Ltd.

192 Nanhai Avenue Xiuying District

570311, Haikou

+86 89 8363 30888

http://www.haiyao.com.cn
address Hainan Haiyao Co., Ltd.(000566)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
HAINAN HAIYAO CO., LTD. Stock Hainan Haiyao Co., Ltd.
-20.35% 647M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+35.01% 709B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.96% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 367B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 334B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.42% 239B
NOVARTIS AG Stock Novartis AG
+9.41% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-4.29% 203B
AMGEN INC. Stock Amgen Inc.
+10.77% 171B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000566 Stock
  4. Company Hainan Haiyao Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW